Intellipharmaceutics International Inc. Annual Share-based Payment Arrangement, Expense in CAD from 2014 to 2018

Taxonomy & unit
us-gaap: CAD and USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Intellipharmaceutics International Inc. annual/quarterly Share-based Payment Arrangement, Expense history and growth rate from 2014 to 2018.
  • Intellipharmaceutics International Inc. Share-based Payment Arrangement, Expense for the quarter ending May 31, 2017 was CA$822K, a 1917% increase year-over-year.
  • Intellipharmaceutics International Inc. annual Share-based Payment Arrangement, Expense for 2018 was CA$928K, a 47% decline from 2017.
  • Intellipharmaceutics International Inc. annual Share-based Payment Arrangement, Expense for 2017 was CA$1.75M, a 22.6% decline from 2016.
  • Intellipharmaceutics International Inc. annual Share-based Payment Arrangement, Expense for 2016 was CA$2.26M, a 441% increase from 2015.
Share-based Payment Arrangement, Expense, Annual (CAD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2018 928K -822K -47% Dec 1, 2017 Nov 30, 2018 20-F/A 2019-03-04
2017 1.75M -511K -22.6% Dec 1, 2016 Nov 30, 2017 20-F/A 2019-03-04
2016 2.26M +1.84M +441% Dec 1, 2015 Nov 30, 2016 20-F/A 2019-03-04
2015 418K -2.06M -83.2% Dec 1, 2014 Nov 30, 2015 20-F 2018-03-01
2014 2.48M Dec 1, 2013 Nov 30, 2014 20-F 2017-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.